Patient | Age yrs | Sex | BMI kg·m−2 | FEV1 % pred | FEV1 L·s−1 | FVC L·s−1 | FEV1/FVC % | GOLD stage |
1 | 64 | M | 26.6 | 40 | 0.95 | 2.35 | 40.3 | III |
2 | 60 | M | 24.8 | 70 | 1.86 | 3.12 | 59.5 | I |
3 | 66 | M | 27.1 | 50 | 1.35 | 2.98 | 45.1 | III |
4 | 69 | M | 29.7 | 61 | 1.59 | 3.15 | 50.3 | II |
5 | 75 | M | 33.5 | 30 | 0.90 | 2.15 | 41.9 | IV |
6 | 60 | M | 32.4 | 40 | 1.01 | 2.21 | 45.8 | III |
7 | 64 | M | 25.0 | 50 | 1.27 | 3.15 | 40.2 | III |
8 | 66 | M | 25.9 | 70 | 1.74 | 2.89 | 60.1 | I |
9 | 71 | M | 26.0 | 38 | 0.90 | 1.89 | 47.4 | III |
10 | 70 | F | 30.1 | 34 | 0.90 | 2.16 | 41.7 | III |
11 | 56 | M | 24.5 | 30 | 0.89 | 2.35 | 38.0 | IV |
12 | 58 | M | 25.3 | 60 | 1.75 | 3.21 | 54.6 | II |
BMI: body mass index; FEV1: forced expiratory volume in one second; % pred: % predicted; FVC: forced vital capacity; GOLD: Global Initiative for Chronic Obstructive Lung Disease; M: male; F: female. FEV1, FVC and FEV1/FVC were measured after bronchodilatation inhalation test.